# A Feasibility Dose-escalating Study of MDT-10013 for Acute Postoperative Pain Following Total Knee Arthroplasty

> **NCT02263222** · PHASE2 · WITHDRAWN · sponsor: **Medtronic Spinal and Biologics**

## Conditions studied

- Post-operation Pain

## Interventions

- **DRUG:** MDT-10013

## Key facts

- **NCT ID:** NCT02263222
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263222, "A Feasibility Dose-escalating Study of MDT-10013 for Acute Postoperative Pain Following Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02263222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*